These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10627887)

  • 1. Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods.
    Haq IU; Ramsay LE; Jackson PR; Wallis EJ
    QJM; 1999 Jul; 92(7):379-85. PubMed ID: 10627887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
    Nam BH; Kannel WB; D'Agostino RB
    Am J Cardiol; 2006 Feb; 97(3):372-5. PubMed ID: 16442398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.
    Wallis EJ; Ramsay LE; Ul Haq I; Ghahramani P; Jackson PR; Rowland-Yeo K; Yeo WW
    BMJ; 2000 Mar; 320(7236):671-6. PubMed ID: 10710573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation.
    Rabindranath KS; Anderson NR; Gama R; Holland MR
    Postgrad Med J; 2002 May; 78(919):269-72. PubMed ID: 12151567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.
    Haq IU; Ramsay LE; Yeo WW; Jackson PR; Wallis EJ
    Heart; 1999 Jan; 81(1):40-6. PubMed ID: 10220543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of cholesterol-lowering primary prevention trials to a general population: the framingham heart study.
    Lloyd-Jones DM; O'Donnell CJ; D'Agostino RB; Massaro J; Silbershatz H; Wilson PW
    Arch Intern Med; 2001 Apr; 161(7):949-54. PubMed ID: 11295957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for cholesterol-lowering medication: comparison of risk-assessment methods.
    Durrington PN; Prais H; Bhatnagar D; France M; Crowley V; Khan J; Morgan J
    Lancet; 1999 Jan; 353(9149):278-81. PubMed ID: 9929020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of current guidelines for primary prevention of coronary heart disease: risk assessment and lipid-lowering therapy.
    Broedl UC; Geiss HC; Parhofer KG
    J Gen Intern Med; 2003 Mar; 18(3):190-5. PubMed ID: 12648250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL cholesterol predicts coronary heart disease mortality in older persons.
    Corti MC; Guralnik JM; Salive ME; Harris T; Field TS; Wallace RB; Berkman LF; Seeman TE; Glynn RJ; Hennekens CH
    JAMA; 1995 Aug; 274(7):539-44. PubMed ID: 7629981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease.
    Hay JW; Sterling KL
    Pharmacoeconomics; 2005; 23(2):133-41. PubMed ID: 15748088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL-cholesterol and cardiac disease: which table to use?
    Bayly G
    Ann Clin Biochem; 2002 Jan; 39(Pt 1):12-21. PubMed ID: 11853184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
    Ferrario M; Chiodini P; Chambless LE; Cesana G; Vanuzzo D; Panico S; Sega R; Pilotto L; Palmieri L; Giampaoli S;
    Int J Epidemiol; 2005 Apr; 34(2):413-21. PubMed ID: 15659467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
    Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F
    Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of triglycerides as a significant independent risk factor in coronary artery disease.
    Assmann G; Schulte H; Funke H; von Eckardstein A
    Eur Heart J; 1998 Oct; 19 Suppl M():M8-14. PubMed ID: 9821011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.